Metabolism-Clinical and Experimental

Article	Citations
Adipose ZFP36 protects against diet-induced obesity and insulin resistance	570
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single and MultipleAscending Dose Study of AMG 133 in Subjects with Obesity	464
Carbohydrate restriction-induced elevations in LDL-cholesterol and atherosclerosis: The KETO Trial	335
Cooperative STAT3-NFkB signaling modulates mitochondrial dysfunction and metabolic profiling in hepatocellular carcinoma	252
PCSK9 in metabolism and diseases	177
Telomere length of the gums of patients with diabetes mellitus in non-alcoholic fatty liver disease	173
Editorial Board	167
miRNAs and Endothelin: A potential nexus in the roadmap for diabetes linked cardiac complications therapeutic strategy	160
Features of myocardial damage indexes in patients with metabolic syndrome and nonalcoholic fatty liver disease	158
The impact of chronic kidney disease in diabetic COVID-19 patients	151
The influence of metformin on the rate of Covid-19 vaccination among diabetes type 2 patients in Poland	144
Features of Ultrastructural Changes in Type II Alveolocytes in Young Rats On the Background of Chronic Hyperglycemia	126
Diet-induced obesity and NASH aggravate SARS-CoV-2 infection in golden Syrian hamsters	117
Vitamin D status and its Association with Atherogenic Index of Plasma in Young Subjects with PCOS	108
Patient perspectives and experiences of basal insulin (BI) titration in type 2 diabetes (T2D): A US cross-sectional survey	107
Gestational Diabetes Mellitus: increased incidence during the COVID-19 pandemic	103
Diabetes mellitus: 100 years since the discovery of insulin	90
Single Nucleotide Variants of the PNPLA3 Gene are Important Genetic Modifiers for the Progression of Metabolically Unhealthy Obesity in Children	89
Efficacy and Safety of Tirzepatide in Type 2 Diabetes: The SURPASS Clinical Trial Program	87
The Conicity Index in Identification of Cardiorenal Metabolic Syndrome Patients at Increased Risk for Complications	87
EMI Not Just BMI: Unveiling Hidden Diabetes Risk Among Apparently Healthy U.S. Young Adults	86
AAV-Mediated Pancreatic Gene Therapy for Type-2 Diabetes	84
Thymoquinone: A Promising Anti-diabetic Molecule!	82
Lifestyle and Affective Emotions in Patients with Type 2 Diabetes Mellitus, With or Without COVID-19 History	79
Editorial Board	76

Hearing loss in inherited metabolic disorders: A systematic review	75
One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs	72
COVID-19 letter to the editor: Epicardial fat inflammation as possible enhancer in COVID-19?	69
Editorial Board	68
Editorial Board	64
Effectiveness and Safety of the Combination of Gliclazide with Metformin in Patients with Diabetes Type 2	63
Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery	63
The Role of Next Generation Sequencing for the Pr ediction of Clinical Outcome in Nonischemic Dilated Cardiomyopathy	62
BODY WEIGHT CHANGE IN HYPERCOLESTROLEMIC RATS MODEL AFTER INTERVENTION WITH AVOCADO (Persea americana Mill) JUICE	61
Comparison of New-Onset Diabetes Mellitus among Patients with Atrial Fibrillation or Atrial Flutter	60
Diabetes knowledge and associated factors in rural Eastern Cape, South Africa: A cross sectional study	59
Modulation of TREM-1, Arginase and Nitric Oxide Levels under Diabetic Conditions in Macrophages	57
Disruptive factors of treatment adherence of diabetic patients in downtown Sfax from Tunisia – a community pharmacy-based survey	56
Comparative efficacy of Gan & Lee insulin aspart (GL-ASP) and EU-marketed insulin aspart (NN-ASP), when combined with metformin, in patients with diabetes mellitus: Post-hoc analyses from a multic	55
Exploring interactions among clustered components of Metabolic Syndrome with diabetes and prediabetes in The Study of Cardiovascular Risk Factors in Adolescents – ERICA Study	55
Autoimmune pancreatitis and its relevance	55
Editorial Board	53
Scientific evaluation of a folk herbal compound for antihyperglycemic and associated bio health markers in chemically induced diabetic rat model	52
Insulin resistance and miR-143/miR-145 relative expression profile is associated with dysregulation in the pathological adiposity setting in aging	51
HSD17B6 delays type 2 diabetes development via inhibiting SREBP activation	50
MiR-21 and MiR-133b are Functionally Associated with Atherosclerotic Coronary Artery Disease by Modulating the Expression of their Novel Targets ATG5, LRP6 and SGPP1	47
Editorial Board	47
Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset	47
Insulin Resistance and Diabetes Modulation with Curcumin: Anti-inflammatory Effects	45
Predicting True Time to Recovery From Insulin-induced Hypoglycemia With Dasiglucagon	44
Myocardial Infarction Increase High RIsk HPV Overall Mortality	44
Analysis of predictors affecting the primary endpoint in patients with ischemic etiology chronic heart failure in combination with prediabetes	44
Interaction between Metabolic syndrome, insulin resistance and oxidative stress in hypertensive patients	43
Diabetic foot osteitis: more than double trouble	43
Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation	42
Mitochondrial dysfunction in diabetic tubulopathy	42
Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitis	42
GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease	42
Eosinophils protect from metabolic alterations triggered by obesity	42
Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects	42
Adipose tissue in older individuals: a contributing factor to sarcopenia	41
Therapeutic importance of eriodictyol in the medicine for the treatment of diabetes and associated complication through its insulin secretagogue properties	41
A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity	40
Reduced Lipotoxicity Following Triple Therapy for 3 Years in New Onset T2DM	40
BMF-219: A Novel Therapeutic Agent to Reestablish Functional Beta Cells and Provide Long-Term Glycemic Control	39
Healthcare Professionals’ Perceptions of Obesity & Agonists of the Glucagon, GLP-1 & GIP Receptors	39
Cannabinoid receptor 2 plays a key role in renal fibrosis through inhibiting lipid metabolism in renal tubular cells	39
Patients Admitted with Diabetic Ketoacidosis and a History of Non-alcoholic Fatty Liver Disease Have a Greater Risk of Mortality and Worse Clinical Outcomes	39
Cytochrome P450 oxidase 2J inhibition suppresses choroidal neovascularization in mice	38
Adipose tissue aging: An update on mechanisms and therapeutic strategies	38
Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study	37
A polyphenol-rich green Mediterranean diet enhances epigenetic regulatory potential: the DIRECT PLUS randomized controlled trial	37
Continuous glucose monitoring in a healthy population: understanding the post-prandial glycemic response in individuals without diabetes mellitus	37
Editorial Board	36
Resistin impairs mitochondrial homeostasis via cyclase-associated protein 1-mediated fission, leading to obesity-induced metabolic diseases	36

Recent advances in closed-loop insulin delivery	36
PPARα-ERRα crosstalk mitigates metabolic dysfunction-associated steatotic liver disease progression	36
The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review	34
Subtypes of type 2 diabetes and their association with outcomes in Korean adults - A cluster analysis of community-based prospective cohort	34
OCTN2 enhances PGC-1α-mediated fatty acid oxidation and OXPHOS to support stemness in hepatocellular carcinoma	34
Insulin regulates arginine-stimulated insulin secretion in humans	34
Weight and organ specific immune cell profiling of sleeve gastrectomy in mice	33
Fasting status and metabolic health in relation to plasma branched chain amino acid concentrations in women	33
LPS-enriched small extracellular vesicles from metabolic syndrome patients trigger endothelial dysfunction by activation of TLR4	33
Blocking IL-6 signaling improves glucose tolerance via SLC39A5-mediated suppression of glucagon secretion	33
Loss of postprandial insulin clearance control by Insulin-degrading enzyme drives dysmetabolism traits	33
Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4	33
Cytoskeleton alterations in non-alcoholic fatty liver disease	32
Mendelian randomization study of obesity and type 2 diabetes in hospitalized COVID-19 patients	31
Systematic review with meta-analysis of diagnostic test accuracy for COVID-19 by mass spectrometry	31
The clustering of Cardiovascular, Renal, Adipo-Metabolic Eye and Liver disease with type 2 diabetes	30
Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease	30
Effects of intraduodenal infusion of lauric acid and L-tryptophan, alone and combined, on glucoregulatory hormones, gastric emptying and glycaemia in healthy men	30
The β-cell glucose toxicity hypothesis: Attractive but difficult to prove	29
Androgen receptor functions in pericentral hepatocytes to decrease gluconeogenesis and avoid hyperglycemia and obesity in male mice	29
Changes in circulating bile acid subtypes in response to weight-loss diets are associated with improvements in glycemic status and insulin resistance: The POUNDS Lost trial	29
Impaired hepatic glucose metabolism and liver-α-cell axis in mice with liver-specific ablation of the Hepatocyte Nuclear Factor 4α (Hnf4a) gene	28
Joint effect of blood pressure and glycemic variation on the risk of cardiovascular morbidity and mortality in persons with type 2 diabetes	28
Primary cilia regulate adaptive responses to fasting	28
Dysregulation of autophagy activation induced by atorvastatin contributes to new-onset diabetes mellitus in western diet-fed mice	27
LncRNA Nron deficiency protects mice from diet-induced adiposity and hepatic steatosis	27
Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy	27
Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control stu	27
Brown adipose tissue-derived metabolites and their role in regulating metabolism	27
Revisiting skeletal myopathy and exercise training in heart failure: Emerging role of myokines	27
The N-degron pathway mediates lipophagy: The chemical modulation of lipophagy in obesity and NAFLD	27
PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy	27
Characterization of tirzepatide-treated patients achieving HbA1c <5.7% in the SURPASS 1-4 trials	26
Association of serum vitamin D level and type 2 diabetes with nonalcoholic fatty liver disease	26
Olfactomedin 4 deletion exacerbates nonalcoholic fatty liver disease through P62-dependent mitophagy in mice	26
Regulation of hepatic lipogenesis by asymmetric arginine methylation	26
Association of fatty liver index with sudden cardiac arrest in young adults	26
LAT1-dependent placental methionine uptake is a key player in fetal programming of metabolic disease	26
A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation	26
Inter-organ cross-talk in human cancer cachexia revealed by spatial metabolomics	25
Hypothalamic SIRT1-mediated regulation of the hormonal trigger of ovulation and its repression in energy deficit	25
COVID-19 and sulfonylureas: A reminder of the pleiotropic actions of an old class of drugs just before their swansong	24
Successful repurposing of empagliflozin to treat neutropenia in a severe congenital neutropenia patient with G6PC3 mutations	24
Central NUCB2/nesfatin-1 signaling ameliorates liver steatosis through suppression of endoplasmic reticulum stress in the hypothalamus	24
Membrane tension sensing formin-binding protein 1 is a neuronal nutrient stress-responsive Golgiphagy receptor	24
Beyond glucose: The crucial role of redox signaling in β-cell metabolic adaptation	24
Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease	23
Epicardial adipose tissue measured from analysis of adipose tissue area using chest CT imaging is the best potential predictor of COVID-19 severity	23
Association between higher consumption of ultra-processed foods and risk of diabetes and its complications: A systematic review & updated meta-analysis	23
Circulating α-klotho regulates metabolism via distinct central and peripheral mechanisms	23
Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond	23
Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice	23
Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis	23
Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists	22
Corrigendum to “Genome-wide association and Mendelian randomization study of fibroblast growth factor 21 reveals causal associations with hyperlipidemia and possibly NASH” [Metab Volume 137, December	22
Fasting-induced miR-7a-5p in AgRP neurons regulates food intake	22
Hepatocyte-specific SLC27A4 deletion ameliorates nonalcoholic fatty liver disease in mice via suppression of phosphatidylcholine-mediated PXR activation	22
New insights into the function of the NLRP3 inflammasome in sarcopenia: mechanism and therapeutic strategies	22
Value of breastfeeding in Pregnant with gestational diabetes mellitus	22
Corrigendum to ‘Targeting mammalian serine/threonine-protein kinase 4 through yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nep	22
Increased plasma fatty acid clearance, not fatty acid concentration, is associated with muscle insulin resistance in people with obesity	22
Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice	21
SUMOylation of ERp44 enhances Ero1α ER retention contributing to the pathogenesis of obesity and insulin resistance	21
Turning sour into sweet: Lactylation modification as a promising target in cardiovascular health	21
Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease	21
Eva1 deficiency prevents obesity-induced metabolic disorders by reducing visceral adipose dysfunction	21
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis	20
Pharmacological inhibition of acyl-coenzyme A:cholesterol acyltransferase alleviates obesity and insulin resistance in diet-induced obese mice by regulating food intake	20
Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes	20
Chemokine receptor CCR1 regulates macrophage activation through mTORC1 signaling in nonalcoholic steatohepatitis	20
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity	20
Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy	20
Ras guanine nucleotide-releasing protein-4 promotes renal inflammatory injury in type 2 diabetes mellitus	20
Metformin-induced TTP mediates communication between Kupffer cells and hepatocytes to alleviate hepatic steatosis by regulating lipophagy and necroptosis	20
The MafA-target gene PPP1R1A regulates GLP1R-mediated amplification of glucose-stimulated insulin secretion in β-cells	19
FSH exacerbates bone loss by promoting osteoclast energy metabolism through the CREB-MDH2-NAD+ axis	19
Mitochondria-SR interaction and mitochondrial fusion/fission in the regulation of skeletal muscle metabolism	19
Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states	19
Future directions in insulin therapy	19
Metformin: Is it a drug for all reasons and diseases?	19

Leptin physiology and pathophysiology in energy homeostasis, immune function, neuroendocrine regulation and bone health	19
Gut-derived ammonia contributes to alcohol-related fatty liver development via facilitating ethanol metabolism and provoking ATF4-dependent de novo lipogenesis activation	19
Glutamine metabolism: from proliferating cells to cardiomyocytes	19
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus	19
Suppressor of cytokine signalling-2 controls hepatic gluconeogenesis and hyperglycemia by modulating JAK2/STAT5 signalling pathway	18
Defining and diagnosing sarcopenia: Is the glass now half full?	18
Advances in physiology, design and development of novel medications changing the landscape of obesity pharmacotherapy	18
Ovarian insufficiency impairs glucose-stimulated insulin secretion through activation of hypothalamic de novo ceramide synthesis	18
Pharmacotherapy of type 2 diabetes: An update and future directions	18
Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD	18
A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on	18
Rising global burden of cancer attributable to high BMI from 2010 to 2019	18
From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need	18
SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study	18
Apolipoprotein C3 aggravates diabetic nephropathy in type 1 diabetes by activating the renal TLR2/NF-κB pathway	18
Suppression of RCAN1 alleviated lipid accumulation and mitochondrial fission in diabetic cardiomyopathy	18
Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease	18
Diacylglycerol kinase delta overexpression improves glucose clearance and protects against the development of obesity	18
Risk of Obesity, Diabetes, Insulin resistance, and Dyslipidemia among Irritable Bowel Syndrome patients	17
Diabetes type 1, HLA genes and celiac disease: an Algerian pediatric cohort	17
The Impact of Processing Methods on Free Fatty Acids Measurements in Type 2 Diabetes	17
Effect of sodium-glucose transport protein 2 inhibitors on all-cause mortality in patients with gout: A multi-center cohort study	17
The Relationship Between Hypertension and Thoracic Spine Bone Mineral Density: The Multi-Ethnic Study of Atherosclerosis (MESA)	17
Higher Resource Utilization And Mortality Among Patients With Heart Failure Admited With Diabetic Ketoacidosis And Chronic Kidney Disease	17
Associations of single nucleotide variants of the FTO gene with metabolic disorders in children with obesity	17
Increased adrenal steroidogenesis and suppressed corticosteroid responsiveness in critical COVID-19	16
Loss of CEACAM1 in endothelial cells causes hepatic fibrosis	16
Inhibition of ACSS2 triggers glycolysis inhibition and nuclear translocation to activate SIRT1/ATG5/ATG2B deacetylation axis, promoting autophagy and reducing malignancy and chemoresistance in ovarian	16
Metabolic complications of highly active antiretroviral therapy in adult HIV-infected patients with heart failure: A 7-year prospective cohort study	16
Exercise alleviates neovascular age-related macular degeneration by inhibiting AIM2 inflammasome in myeloid cells	16
Basal weekly insulins: the way of the future!	16
Diabetic kidney disease in type 1 diabetes: challenges and differences from type 2 diabetes	16
Corrigendum to “FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis” [Metabolism 122 (September 2021) 154840]	16
Growth Differentiation Factor 15 (GDF-15) Levels Associated with the Presence and Severity of NAFLD	16
Corrigendum to “Imeglimin improves systemic metabolism by targeting brown adipose tissue and gut microbiota in obese model mice” [Metabolism 153 (April 2024) 155796]	16
Relationship between Obesity Indices Measured with Body Composition Analyzer and Carotid Artery Plaques in Korean Middle-Aged Men	15
Effect of oral contraceptives on energy balance in women: A review of current knowledge and potential cellular mechanisms	15
Editorial Board	15
Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysis	15
COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic	15
TAS2R38 taste receptor gene and metabolically unhealthy obesity	15
Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters	15
The relationship between Vitamin D level and Sarcopenia: Insights from a Korean Population Study	15
Editorial Board	15
The exoWAT, endoWAT and ectoWAT Dictate Dysmetabolism, Dyslipidemia and Diabetes	15
Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending?	15
Epidemiological study on short and long-term weight loss with improvement of metabolic control in obese diabetic patients with a standardized multidisciplinary weight loss program (DIAMEX Study).	14
Evaluation of response to clopidogrel therapy in patients with acute coronary syndrome by platelet aggregation method	14
Editorial Board	14
Alpha-lipoic acid as an alternative treatment for diabetic polyneuropathy?	14
Editorial Board	14
Angiotensin II type 1 receptor-associated protein in immune cells: a possible key factor in the pathogenesis of visceral obesity	14
Compensated hypogonadism and erectile dysfunction in type 2 diabetes (n=120)	14
Sitagliptin on carotid intima-media thickness in type 2 diabetes and hyperuricemia patients: A subgroup analysis of the PROLOGUE study	14
Co-administration of metformin and intranasal insulin more effectively restores the metabolic and hormonal parameters in diabetic rats in comparison with monotherapy	14
Association between hypertension and severity of NAFLD among adults with obesity	14
Editorial Board	14
Omega-3 Fatty Acids intervention and DASH Diet Ameliorates Metabolic profiling in Patients with Diabetes Mellitus Type 2	14
Maternal weight gain associated with vitamin D deficiency and treatment outcome	14
Effects of Newer Antidiabetic Agents on Cardiovascular Outcomes in Older Adults: Systematic Review and Meta-analysis	13
Prognostic Fasting Insulin Cut Points for Hidden Diabetes Risk among Apparently Healthy Young Adults: CARDIA 30-year Follow Up	13
Sub Phenotyping of Type 2 Diabetes Using Data-driven Cluster Analysis	13
Empagliflozin Improves Heart Failure with Preserved Ejection Fraction Despite Limited Effects on NASH in Non-diabetic and Diabetic Diet-induced Obese Hamsters	13
Pegozafermin Led to Significant Metabolic Benefits, in Addition to Robust Beneficial Effects on the Liver, in an Open-label Cohort of a Phase 1b/2a Study in Subjects with Non-alcoholic Steatohepatitis	13
miRNAs as a Therapeutic Target for Vascular Dysfunction in Diabetes	13
Letter to the Editor: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences	13
Effects of metformin and lutheinizing hormone receptor agonists on steroidogenesis and spermatogenesis in rats with type 2 diabetes with their separate and combined administration	13
Correlation between Blood Glucose and Insulin Secretion during Oral Glucose Tolerance Test and Diabetes Risk in Obese Patients	13
Long-term Clinical Outcomes and Mediating Mechanistic Effects of Bariatric Surgery on Adipokines and Gastrointestinal Hormone Secretion: The First 10-year Long Longitudinal and Case-cohort Study	13
A Rare Cause of Severe Insulin Resistance: A Case Report	13
Role Of Inflammation in Development of Insulin Resistance in First Degree Relatives (FDR) Of Subjects with Diabetes	13
Nutritional Intervention in Patients with Type 2 Diabetes	12
Insulin resistance susceptibility is associated with BPA exposure	12
Blood based biomarkers as non-invasive screening tools for hepatic fibrosis in subjects with Type 2 Diabetes Mellitus	12
Leveraging Automated Machine Learning to provide NAFLD screening diagnosis: Proposed machine learning models	12
Using Healthcare Claims Data and Machine Learning to Identify Health Disparities for Individuals with Diagnosed and Undiagnosed Familial Hypercholesterolemia	12
EVALUATION OF 1-HOUR POST LOAD GLUCOSE LEVELS, THE METABOLIC SYNDROME AND FINDRISC SCORES IN THE PREDICTION OF T2DM IN PATIENTS WITH IMPAIRED FASTING GLUCOSE	12
Anti-atherosclerosis activity of meranzin hydrate in the medicine: Therapeutic benefit through scientific data analysis	12
The Effect of Diabetes Mellitus and Revascularization Status on Cardiorespiratory Fitness in Multi-vessel Acute Coronary Syndrome Patients	12
The Association Between Gestational Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Systematic Literature Review	12
Gender Differences in the Association Between Perfluoroalkyl Substances and Mortality	12
Prevalence of Insulin Resistance Among Women with PCOS and Impaired Fertility in an Albanian Population	12
Chronic Inflammation Associated with Elevated Blood Levels in Children	12
Biological importance of cirsiliol on xanthine oxidase for the treatment of renal disorders: Medicinal uses and therapeutic importance	12
Influence of metabolic syndrome components in the course of covid-19 in patients with nonalcoholic fatty liver disease	12
Biological potential and antioxidant activity of irisolidone in the medicine through scientific data analysis	12
Low-risk HPV Strains and Obesity Lead to Increased Long-term Mortality	12